Freeflow recently hosted Unlocking the Translational Potential of University Innovation, a virtual panel featuring the founders of Freeflow portfolio companies Appia Bio, TooFon, and Entos and Freeflow institutional investor Ahoy Capital.
Freeflow Managing Partner David Fleck was joined by Freeflow Partner Kevin Barrett and the following founders:
- Chris Douvos, Founder, Ahoy Capital
- JJ Kang, Founding CEO, Appia Bio
- Mory Gharib, Founder, TooFon
- Tom Miller, Founder, Entos
Other articles
October 30, 2024
Holoclara: Developing Allergic and Autoimmune Disease Relief by Using Worms
Holoclara is a Freeflow Fund One portfolio company that discovers, develops and…
October 10, 2024
Membrion: Solving for Wastewater Recovery
Membrion is a Freeflow Fund Two portfolio company led by Founder & CEO Greg…
September 25, 2024
Wild Microbes: Scaling New Bioproducts
Wild Microbes is a Freeflow Fund Two portfolio company founded by Tim Wannier…